Three Things to Know Before You Cancel Your Mammogram

D. Randolph Drosick, MD, medical oncologist and hematologist who specializes in breast cancer

More than six months into the COVID-19 pandemic, fears are growing about the long-term impact on cancer rates. Put simply, Americans are skipping their screenings and the potential consequences are a major concern of OHC’s breast cancer experts.... Read More

OHC doctors are evaluating new treatment for women with advanced ovarian cancer.

Dené C. Wrenn, MD, MS, gynecologic oncologist with OHC

For many women diagnosed with ovarian cancer, their initial treatment, which typically includes chemotherapy, will stop the cancer’s growth. Unfortunately, many of these patients later experience a relapse. Even though the chemotherapy initially... Read More

OHC Exclusively Offers New Immunotherapy Treatment for Advanced Cervical Cancer

Ajit Gubbi, DO, Gynecologic Oncologist with OHC

In the past 40 years, the number of cases of cervical cancer and the number of deaths from cervical cancer have decreased significantly. This encouraging trend is due in large part to early detection through Pap tests, the recent introduction of the... Read More

OHC is Helping Change the Lives of Patients with Breast Cancer through Clinical Trials

Patrick J. Ward, MD, PhD, Medical Oncologist, Hematologist and Co-Director of Research at OHC

Breast cancer is no longer the most common cancer for women in the United States. This is due to decades of efforts like Breast Cancer Awareness Month that have increased awareness of the benefits of breast cancer screenings and self-exams, which... Read More

OHC doctors are evaluating two new treatments for classic Hodgkin lymphoma that may offer fewer, milder side effects.

Miguel Islas-Ohlmayer, MD, Medical Oncologist, Hematologist, and Transplant Specialist at OHC

Classical Hodgkin lymphoma (CHL) is considered a highly treatable blood cancer. Advancements in diagnosis and treatment have helped give people with this disease the chance for a full recovery. However, 20 percent of CHL patients do not respond... Read More

Pink Ribbon Girls Helps When Cancer Makes Daily Activities a Challenge

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

For women who receive a breast cancer diagnosis, OHC will lead you through your cancer journey and surround you with the treatments and services you need to beat your disease. Some patients may experience fatigue and nausea from the treatment, which... Read More

Unique program pairs cancer patients with cancer survivors who’ve “been there.”

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Paige Shapiro is one of the fortunate ones. She has survived ovarian cancer. This year in the U.S., approximately 14,000 women will not be as fortunate as Paige. They will lose their battle with ovarian cancer, mostly due to the lack of an early... Read More

OHC is helping tackle the ongoing challenges of ovarian cancer

Marcia C. Bowling, MD, Gynecologic Oncologist with OHC

During my career as a gynecologic oncologist with OHC, my colleagues and I have seen some remarkable advancements in the treatment of ovarian cancer. This includes the introduction of robotic-assisted surgery, new FDA-approved drugs, and promising... Read More

Cancer Doctors Warn Thirty-somethings: Be Aware of Testicular Cancer

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Testicular cancer is one of the most commonly diagnosed cancers in young adult men, particularly between ages 30 to 39. If the cancer hasn’t spread, the survival rate is 99%. However, once it has spread to other organs, the survival rate drops to... Read More

Cancer Experts at OHC are Evaluating a New Treatment for Older Adults with Acute Myeloid Leukemia

OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders

Although acute myeloid leukemia (AML) accounts for only about one percent of all cancers, it can be deadly if not treated. Approximately two out of three people with AML who receive standard chemotherapy go into remission. The chance of remission... Read More